Progesterone receptor gene variants and risk of endometrial cancer.
暂无分享,去创建一个
K. Czene | P. Hall | T. Rebbeck | A. Spurdle | D. Lambrechts | A. Dunning | Shahana Ahmed | Jianjun Liu | M. Shah | I. Vergote | F. Amant | P. Fahey | P. Webb | K. Ferguson | T. O’Mara | E. Despierre | L. Marquart | C. S. Gregory | P. Hall
[1] B. Henderson,et al. Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach. , 2010, Carcinogenesis.
[2] J. Long,et al. Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population , 2009, Cancer.
[3] A. Spurdle,et al. Re: Excess of early onset multiple myeloma in endometrial cancer probands and their relatives suggests common susceptibility. , 2008, Gynecologic oncology.
[4] A. Whittemore,et al. Association Between Single-Nucleotide Polymorphisms in Hormone Metabolism and DNA Repair Genes and Epithelial Ovarian Cancer: Results from Two Australian Studies and an Additional Validation Set , 2007, Cancer Epidemiology Biomarkers & Prevention.
[5] H. Sasano,et al. Biological roles of estrogen and progesterone in human endometrial carcinoma--new developments in potential endocrine therapy for endometrial cancer. , 2007, Endocrine journal.
[6] Kiyoshi Ito,et al. Hormone replacement therapy and cancers: the biological roles of estrogen and progestin in tumorigenesis are different between the endometrium and breast. , 2007, The Tohoku journal of experimental medicine.
[7] T. Rebbeck,et al. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. , 2006, American journal of epidemiology.
[8] I. da Silva,et al. Progesterone receptor (PROGINS) polymorphism and the risk of endometrial cancer development , 2006, International Journal of Gynecologic Cancer.
[9] E. Weiderpass,et al. No Association between Progesterone Receptor Gene +331G/A Polymorphism and Endometrial Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.
[10] A. Romano,et al. Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinoma , 2005, The Journal of pathology.
[11] I. B. Van den Veyver,et al. Recurrent pregnancy loss due to familial and non‐familial habitual molar pregnancy , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[12] P. Boyle,et al. Cancer control in women. Update 2003 , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[13] E. Steiner,et al. Multivariate independent prognostic factors in endometrial carcinoma: A clinicopathologic study in 181 patients 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University , 2003, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[14] R. Kaaks,et al. Obesity , Endogenous Hormones , and Endometrial Cancer Risk : A Synthetic Review 1 , 2002 .
[15] G. Colditz,et al. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[16] G. Heinze,et al. Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients , 2001, International journal of cancer.
[17] I Persson,et al. Risk of endometrial cancer following estrogen replacement with and without progestins. , 1999, Journal of the National Cancer Institute.
[18] Caroline Portmann,et al. The laboratory assistant , 1999 .
[19] P Chambon,et al. Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. , 1990, The EMBO journal.
[20] G. Sutton,et al. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. , 1988, American journal of obstetrics and gynecology.
[21] M. Pike,et al. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. , 1988, British Journal of Cancer.